Christian Lind Nielsen, Daniel Thor Halberg Dybdal, Peter Vester-Glowinski, Lisa Lyngsie Hjalgrim, Pernille Edslev Wendtland, Birgitte Jul Kiil, Michael Melchior Bendtsen, Michael Mørk Petersen, Thomas Baad-Hansen
{"title":"在丹麦,肿瘤切除后带血管的腓骨移植显示出可接受的长期结果:一项全国回顾性队列研究。","authors":"Christian Lind Nielsen, Daniel Thor Halberg Dybdal, Peter Vester-Glowinski, Lisa Lyngsie Hjalgrim, Pernille Edslev Wendtland, Birgitte Jul Kiil, Michael Melchior Bendtsen, Michael Mørk Petersen, Thomas Baad-Hansen","doi":"10.2340/17453674.2025.42848","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong> Vascularized fibular grafting following tumor resection is an essential treatment option in limb salvage surgery. We aimed to evaluate: (I) bone healing, (II) complications and reoperations, (III) limb salvage, and (IV) survival.</p><p><strong>Methods: </strong> We present a retrospective evaluation of a national cohort comprising 27 patients. The indications were 13 cases of Ewing sarcoma, 12 cases of osteosarcoma, and 2 cases of giant cell tumor. The median age at surgery was 16 years (interquartile range [IQR] 10-18), and the median follow-up was 82 months (IQR 32-101). Patients were analyzed overall, as well as in subgroups based on tumor location (upper versus lower extremity) and pathology (osteosarcoma versus Ewing sarcoma).</p><p><strong>Results: </strong> The primary rate of graft union was 63%, and after secondary procedures the overall rate of graft union was 67%, with a median time to union of 13 months (IQR 9-17). The reoperation rate was 74%, while the limb salvage rate was 93%. The 5-year overall survival rate was 81% (95% confidence interval [CI] 61-92). Patients with upper extremity tumors were more likely to attain graft union (risk ratio [RR] 5.5, CI 1.3-31.5) and less likely to undergo multiple reoperations (RR 0.3, CI 0.8-0.9) than patients with lower extremity tumors.</p><p><strong>Conclusion: </strong> Vascularized fibular grafting following tumor resection was associated with a graft union rate of 67%, a high frequency of reoperations, a high limb salvage rate (93%), and a 5-year survival rate of 81%.</p>","PeriodicalId":6916,"journal":{"name":"Acta Orthopaedica","volume":"96 ","pages":"87-93"},"PeriodicalIF":2.5000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734533/pdf/","citationCount":"0","resultStr":"{\"title\":\"Vascularized fibular grafting following tumor resection demonstrates acceptable long-term outcomes in Denmark: a national retrospective cohort study.\",\"authors\":\"Christian Lind Nielsen, Daniel Thor Halberg Dybdal, Peter Vester-Glowinski, Lisa Lyngsie Hjalgrim, Pernille Edslev Wendtland, Birgitte Jul Kiil, Michael Melchior Bendtsen, Michael Mørk Petersen, Thomas Baad-Hansen\",\"doi\":\"10.2340/17453674.2025.42848\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong> Vascularized fibular grafting following tumor resection is an essential treatment option in limb salvage surgery. We aimed to evaluate: (I) bone healing, (II) complications and reoperations, (III) limb salvage, and (IV) survival.</p><p><strong>Methods: </strong> We present a retrospective evaluation of a national cohort comprising 27 patients. The indications were 13 cases of Ewing sarcoma, 12 cases of osteosarcoma, and 2 cases of giant cell tumor. The median age at surgery was 16 years (interquartile range [IQR] 10-18), and the median follow-up was 82 months (IQR 32-101). Patients were analyzed overall, as well as in subgroups based on tumor location (upper versus lower extremity) and pathology (osteosarcoma versus Ewing sarcoma).</p><p><strong>Results: </strong> The primary rate of graft union was 63%, and after secondary procedures the overall rate of graft union was 67%, with a median time to union of 13 months (IQR 9-17). The reoperation rate was 74%, while the limb salvage rate was 93%. The 5-year overall survival rate was 81% (95% confidence interval [CI] 61-92). Patients with upper extremity tumors were more likely to attain graft union (risk ratio [RR] 5.5, CI 1.3-31.5) and less likely to undergo multiple reoperations (RR 0.3, CI 0.8-0.9) than patients with lower extremity tumors.</p><p><strong>Conclusion: </strong> Vascularized fibular grafting following tumor resection was associated with a graft union rate of 67%, a high frequency of reoperations, a high limb salvage rate (93%), and a 5-year survival rate of 81%.</p>\",\"PeriodicalId\":6916,\"journal\":{\"name\":\"Acta Orthopaedica\",\"volume\":\"96 \",\"pages\":\"87-93\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-01-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11734533/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Orthopaedica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2340/17453674.2025.42848\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Orthopaedica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2340/17453674.2025.42848","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
摘要
背景与目的:肿瘤切除后带血管腓骨移植是保肢手术的重要治疗选择。我们的目的是评估:(I)骨愈合,(II)并发症和再手术,(III)肢体保留,(IV)生存。方法:我们对一个包括27例患者的国家队列进行回顾性评估。适应症为尤文氏肉瘤13例,骨肉瘤12例,巨细胞瘤2例。手术时中位年龄为16岁(四分位间距[IQR] 10-18),中位随访时间为82个月(IQR 32-101)。对患者进行整体分析,并根据肿瘤位置(上肢与下肢)和病理(骨肉瘤与尤文氏肉瘤)进行亚组分析。结果:初次植骨愈合率为63%,二次手术后总植骨愈合率为67%,平均愈合时间为13个月(IQR 9-17)。再手术率为74%,肢体保留率为93%。5年总生存率为81%(95%可信区间[CI] 61-92)。上肢肿瘤患者比下肢肿瘤患者更容易获得移植物愈合(风险比[RR] 5.5, CI 1.3 ~ 31.5),多次再手术的可能性更低(RR 0.3, CI 0.8 ~ 0.9)。结论:肿瘤切除后带血管腓骨移植术后移植物愈合率达67%,再手术率高,残肢保留率高(93%),5年生存率达81%。
Vascularized fibular grafting following tumor resection demonstrates acceptable long-term outcomes in Denmark: a national retrospective cohort study.
Background and purpose: Vascularized fibular grafting following tumor resection is an essential treatment option in limb salvage surgery. We aimed to evaluate: (I) bone healing, (II) complications and reoperations, (III) limb salvage, and (IV) survival.
Methods: We present a retrospective evaluation of a national cohort comprising 27 patients. The indications were 13 cases of Ewing sarcoma, 12 cases of osteosarcoma, and 2 cases of giant cell tumor. The median age at surgery was 16 years (interquartile range [IQR] 10-18), and the median follow-up was 82 months (IQR 32-101). Patients were analyzed overall, as well as in subgroups based on tumor location (upper versus lower extremity) and pathology (osteosarcoma versus Ewing sarcoma).
Results: The primary rate of graft union was 63%, and after secondary procedures the overall rate of graft union was 67%, with a median time to union of 13 months (IQR 9-17). The reoperation rate was 74%, while the limb salvage rate was 93%. The 5-year overall survival rate was 81% (95% confidence interval [CI] 61-92). Patients with upper extremity tumors were more likely to attain graft union (risk ratio [RR] 5.5, CI 1.3-31.5) and less likely to undergo multiple reoperations (RR 0.3, CI 0.8-0.9) than patients with lower extremity tumors.
Conclusion: Vascularized fibular grafting following tumor resection was associated with a graft union rate of 67%, a high frequency of reoperations, a high limb salvage rate (93%), and a 5-year survival rate of 81%.
期刊介绍:
Acta Orthopaedica (previously Acta Orthopaedica Scandinavica) presents original articles of basic research interest, as well as clinical studies in the field of orthopedics and related sub disciplines. Ever since the journal was founded in 1930, by a group of Scandinavian orthopedic surgeons, the journal has been published for an international audience. Acta Orthopaedica is owned by the Nordic Orthopaedic Federation and is the official publication of this federation.